This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Oct 18;372(9647):1382-3; author reply 1383.

doi: 10.1016/S0140-6736(08)61581-0.

Statistical treatment of withdrawal in trials of anti-dementia drugs

Andrew Mackinnon

PMID: 18940460
DOI: 10.1016/S0140-6736(08)61581-0

Comment

Statistical treatment of withdrawal in trials of anti-dementia drugs

Andrew Mackinnon. Lancet. 2008.

. 2008 Oct 18;372(9647):1382-3; author reply 1383.

doi: 10.1016/S0140-6736(08)61581-0.

Author

Andrew Mackinnon

PMID: 18940460
DOI: 10.1016/S0140-6736(08)61581-0

No abstract available

PubMed Disclaimer

Comment on

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study.
Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D; dimebon investigators. Doody RS, et al. Lancet. 2008 Jul 19;372(9634):207-15. doi: 10.1016/S0140-6736(08)61074-0. Lancet. 2008. PMID: 18640457 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science